WMJ-J-09 is a novel hydroxamate-based HDAC inhibitor that induces tumor cell apoptosis by activating the LKB1-AMPK signaling cascade and downregulating Survivin.
Molecular Weight:
445.53
Purity:
99.86%
CAS Number:
[2416914-29-7]
Formula:
C22H27N3O5S
Target:
HDAC
* VAT and and shipping costs not included. Errors and price changes excepted